Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2017

01-09-2017 | UNM Clinical Case Conferences

Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?

Authors: Anas Gremida, Ahmad Al-Taee, Joseph Alcorn, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 9/2017

Login to get access

Excerpt

A 55-year-old Caucasian male, with history of type 2 diabetes mellitus and benign prostatic hyperplasia, was initially evaluated in emergency department with a 2-month history of worsening jaundice, pruritus, and right upper quadrant abdominal pain. His gallbladder had previously been removed. Medications included insulin and tamsulosin. He had a 20 pack-year history of smoking. He denied ever drinking alcohol to excess or using illicit drugs. On presentation, his vital signs were within normal limits. Physical examination revealed only scleral icterus, diffuse skin excoriations on the extremities and torso, and abdominal tenderness to palpation over the right upper quadrant. The liver span was normal; the spleen was not enlarged, and there was no lymphadenopathy or peripheral edema. …
Literature
1.
go back to reference Stauffer M. Nephrogenic hepatosplenomegaly. Gastroenterology. 1961;40:694. Stauffer M. Nephrogenic hepatosplenomegaly. Gastroenterology. 1961;40:694.
2.
go back to reference Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer. 1997;72:424–430.CrossRefPubMed Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer. 1997;72:424–430.CrossRefPubMed
3.
go back to reference Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol. 1996;14:216–222.PubMed Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol. 1996;14:216–222.PubMed
5.
go back to reference Hinostroza-Yanahuaya J, Mon-Mon C, Ortega-Marcos O, Herrero-Berron JC, et al. Stauffer syndrome and prostate carcinoma; two cases in chronic haemodialysis patients. Nefrologia. 2013;33:749–750.PubMed Hinostroza-Yanahuaya J, Mon-Mon C, Ortega-Marcos O, Herrero-Berron JC, et al. Stauffer syndrome and prostate carcinoma; two cases in chronic haemodialysis patients. Nefrologia. 2013;33:749–750.PubMed
6.
go back to reference Saintigny P, Spano JP, Tcherakian F, Pailler MC, et al. Non-metastatic intrahepatic cholestasis associated with bronchial adenocarcinoma. Ann Med Intern. 2003;154:171–175. Saintigny P, Spano JP, Tcherakian F, Pailler MC, et al. Non-metastatic intrahepatic cholestasis associated with bronchial adenocarcinoma. Ann Med Intern. 2003;154:171–175.
7.
go back to reference Sharara AI, Panella TJ, Fitz JG. Paraneoplastic hepatopathy associated with soft tissue sarcoma. Gastroenterology. 1992;103:330–332.CrossRefPubMed Sharara AI, Panella TJ, Fitz JG. Paraneoplastic hepatopathy associated with soft tissue sarcoma. Gastroenterology. 1992;103:330–332.CrossRefPubMed
8.
go back to reference Moreno-Palacios J, Wingartz-Plata H, Pardo-Belasteguigoitia P, Moreno-Aranda J. Stauffer syndrome in transitional cell carcinoma of the bladder. Arch Esp Urol. 2011;64:911–913.PubMed Moreno-Palacios J, Wingartz-Plata H, Pardo-Belasteguigoitia P, Moreno-Aranda J. Stauffer syndrome in transitional cell carcinoma of the bladder. Arch Esp Urol. 2011;64:911–913.PubMed
9.
go back to reference Watterson J, Priest JR. Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. Gastroenterology. 1989;97:1319–1322.CrossRefPubMed Watterson J, Priest JR. Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. Gastroenterology. 1989;97:1319–1322.CrossRefPubMed
10.
go back to reference Mendogni P, Rosso L, Tosi D, Palleschi A, et al. Autoimmune hepatitis: an uncommon presentation of thymoma. Tumori. 2016;102:40–42.CrossRef Mendogni P, Rosso L, Tosi D, Palleschi A, et al. Autoimmune hepatitis: an uncommon presentation of thymoma. Tumori. 2016;102:40–42.CrossRef
11.
go back to reference Oguro T, Ishibashi K, Sugino T, Hashimoto K, et al. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression. Eur J Cancer. 2013;49:1715–1724.CrossRefPubMed Oguro T, Ishibashi K, Sugino T, Hashimoto K, et al. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression. Eur J Cancer. 2013;49:1715–1724.CrossRefPubMed
13.
go back to reference Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, et al. Transient autoimmune hepatitis induced by a thymoma. Am J Gastroenterol. 2009;104:1332–1334.CrossRefPubMed Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, et al. Transient autoimmune hepatitis induced by a thymoma. Am J Gastroenterol. 2009;104:1332–1334.CrossRefPubMed
14.
go back to reference Chang S, Yu D, Sherwood E, Koslowski J, et al. Inhibitory effects of Suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction. J Urol. 1992;47:1147–1150.CrossRef Chang S, Yu D, Sherwood E, Koslowski J, et al. Inhibitory effects of Suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction. J Urol. 1992;47:1147–1150.CrossRef
15.
go back to reference Chuang YC, Lin AT, Chen KK, Chang YH, et al. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. J Urol. 1997;158:1684–1687.CrossRefPubMed Chuang YC, Lin AT, Chen KK, Chang YH, et al. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. J Urol. 1997;158:1684–1687.CrossRefPubMed
16.
go back to reference Strickland RC, Schenker S. The nephrogenic hepatic dysfunction syndrome: a review. Am J Dig Dis. 1977;22:49–55.CrossRefPubMed Strickland RC, Schenker S. The nephrogenic hepatic dysfunction syndrome: a review. Am J Dig Dis. 1977;22:49–55.CrossRefPubMed
17.
go back to reference Delpre G, Ilie B, Papo J, Streifler C, et al. Hypernephroma with nonmetastatic liver dysfunction (Stauffer’s syndrome) and hypercalcemia. Case report and review of the literature. Am J Gastroenterol. 1979;72:239–427.PubMed Delpre G, Ilie B, Papo J, Streifler C, et al. Hypernephroma with nonmetastatic liver dysfunction (Stauffer’s syndrome) and hypercalcemia. Case report and review of the literature. Am J Gastroenterol. 1979;72:239–427.PubMed
18.
go back to reference Puga M, Gonzalez-Ballina E, Rivas-Moral L. Stauffer’s syndrome: variant as an unusual case of painless jaundice. Clin Gastroenterol Hepatol. 2015;13:25–26.CrossRef Puga M, Gonzalez-Ballina E, Rivas-Moral L. Stauffer’s syndrome: variant as an unusual case of painless jaundice. Clin Gastroenterol Hepatol. 2015;13:25–26.CrossRef
19.
go back to reference Jangouk P, Hashash JG. An unusual cause of painless jaundice. Renal cell carcinoma (Stauffer syndrome). Gastroenterology. 2014;146:913.CrossRefPubMed Jangouk P, Hashash JG. An unusual cause of painless jaundice. Renal cell carcinoma (Stauffer syndrome). Gastroenterology. 2014;146:913.CrossRefPubMed
20.
go back to reference Akbulut S, Baysal A, Topal F. Paraneoplastic presentation of cholestatic jaundice in renal cell carcinoma. Turk J Gastroenterol. 2014;25:340–341.CrossRefPubMed Akbulut S, Baysal A, Topal F. Paraneoplastic presentation of cholestatic jaundice in renal cell carcinoma. Turk J Gastroenterol. 2014;25:340–341.CrossRefPubMed
21.
go back to reference Fernandez AB, De Avila AS. Prothrombin complex concentrate (Octaplex(R)) for postsurgical bleeding control in a Stauffer’s syndrome. Ann Hematol. 2012;91:1325–1326.CrossRefPubMed Fernandez AB, De Avila AS. Prothrombin complex concentrate (Octaplex(R)) for postsurgical bleeding control in a Stauffer’s syndrome. Ann Hematol. 2012;91:1325–1326.CrossRefPubMed
22.
go back to reference Woldie I, Manickam P, Choi M, Shi D, et al. An infrequent variant of Stauffer’s syndrome. Acta Gastroenterol Belg. 2012;75:379–380.PubMed Woldie I, Manickam P, Choi M, Shi D, et al. An infrequent variant of Stauffer’s syndrome. Acta Gastroenterol Belg. 2012;75:379–380.PubMed
23.
go back to reference Tomadoni A, García C, Márquez M, Ayala JC, et al. Stauffer’s syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report. Arch Esp Urol. 2010;63:154–156.CrossRefPubMed Tomadoni A, García C, Márquez M, Ayala JC, et al. Stauffer’s syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report. Arch Esp Urol. 2010;63:154–156.CrossRefPubMed
24.
go back to reference Girotra M, Abraham RR, Pahwa M, Arora M. Is Stauffer’s syndrome an early indicator of RCC recurrence? ANZ J Surg. 2010;80:949–950.CrossRefPubMed Girotra M, Abraham RR, Pahwa M, Arora M. Is Stauffer’s syndrome an early indicator of RCC recurrence? ANZ J Surg. 2010;80:949–950.CrossRefPubMed
25.
go back to reference Kranidiotis GP, Voidonikola PT, Dimopoulos MK, Anastasiou-Nana M. Stauffer’s syndrome as a prominent manifestation of renal cancer: a case report. Cases J. 2009;2:49–52.CrossRefPubMedPubMedCentral Kranidiotis GP, Voidonikola PT, Dimopoulos MK, Anastasiou-Nana M. Stauffer’s syndrome as a prominent manifestation of renal cancer: a case report. Cases J. 2009;2:49–52.CrossRefPubMedPubMedCentral
26.
go back to reference Yong TL, Birks SE, Rudinski C. Stauffer’s syndrome. ANZ J Surg. 2008;78:1138–1139.PubMed Yong TL, Birks SE, Rudinski C. Stauffer’s syndrome. ANZ J Surg. 2008;78:1138–1139.PubMed
27.
go back to reference Morla D, Alazemi S, Lichtstein D. Stauffer’s syndrome variant with cholestatic jaundice: a case report. J Gen Intern Med. 2006;21:11–13.CrossRef Morla D, Alazemi S, Lichtstein D. Stauffer’s syndrome variant with cholestatic jaundice: a case report. J Gen Intern Med. 2006;21:11–13.CrossRef
28.
go back to reference Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, et al. Stauffer’s syndrome variant associated with renal cell carcinoma. Int J Urol. 2005;12:757–759.CrossRefPubMed Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, et al. Stauffer’s syndrome variant associated with renal cell carcinoma. Int J Urol. 2005;12:757–759.CrossRefPubMed
29.
go back to reference Dourakis SP, Sinani C, Deutsch M, Dimitriadou E, et al. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol. 1997;9:311–314.CrossRefPubMed Dourakis SP, Sinani C, Deutsch M, Dimitriadou E, et al. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol. 1997;9:311–314.CrossRefPubMed
30.
go back to reference Fang JW, Lau JY, Wu PC, Lai CL. Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci. 1992;37:474–477.CrossRefPubMed Fang JW, Lau JY, Wu PC, Lai CL. Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci. 1992;37:474–477.CrossRefPubMed
Metadata
Title
Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?
Authors
Anas Gremida
Ahmad Al-Taee
Joseph Alcorn
Denis McCarthy
Publication date
01-09-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4706-8

Other articles of this Issue 9/2017

Digestive Diseases and Sciences 9/2017 Go to the issue